Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
More research is needed for better informed policy and practice decisions for the use of telehealth, according to a draft technical brief from the Agency for Healthcare Research and Quality.
The U.S. market for remote patient management is projected to grow by 13 percent over the next five years, according to an analysis from Frost & Sullivan.
Managed-care behemoth Kaiser Permanente, the $56 billion nonprofit that integrates healthcare plans with provider entities in eight states plus the District of Columbia, has announced that it is getting into the business of medical education.
Bill Frist, MD, former U.S. Senator, is in the process of forming a new venture capital group to handle his and his partner's personal investments healthcare technology, according to Fortune.
Four foundations have come together to provide OpenNotes with $10 million in new funding to spread access to clinical notes to 50 million patients.
The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.
The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks.
Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.
